Mapping IL-13

CE / CME

Mapping IL-13 to the Clinical Manifestations of Atopic Dermatitis

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Released: January 31, 2025

Expiration: January 30, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Jane, a 34-year-old female with severe atopic dermatitis (AD), presents with persistent symptoms including redness, itching, and scaling despite using topical corticosteroids and emollients. Her condition has worsened during the past year, and she reports sleep disruption caused by itching. Laboratory findings show an elevated immunoglobulin E level and eosinophilia.

Based on the role of interleukin (IL)-13 in AD, which of the following best describes its pathophysiologic contributions to Jane’s clinical manifestations?